These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 3215246)
1. Hormonal consequences of orchidectomy for carcinoma of the prostate. With special reference to the measurement of free testosterone in saliva and prostatic dihydrotestosterone levels. Boccon-Gibod L; Laudat MH; Guiban D; Steg A Eur Urol; 1988; 15(1-2):99-102. PubMed ID: 3215246 [TBL] [Abstract][Full Text] [Related]
2. Hormonal consequences of orchidectomy for carcinoma of the prostate. With special reference to the measurement of free testosterone in the saliva. Boccon-Gibod L; Laudat MH; Guiban D; Steg A Prog Clin Biol Res; 1987; 243A():45-53. PubMed ID: 3659006 [TBL] [Abstract][Full Text] [Related]
3. Peripheral hormone levels in controls and patients with prostatic cancer or benign prostatic hyperplasia: results from the Dutch-Japanese case-control study. de Jong FH; Oishi K; Hayes RB; Bogdanowicz JF; Raatgever JW; van der Maas PJ; Yoshida O; Schroeder FH Cancer Res; 1991 Jul; 51(13):3445-50. PubMed ID: 1711411 [TBL] [Abstract][Full Text] [Related]
4. Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer. Heracek J; Hampl R; Hill M; Starka L; Sachova J; Kuncova J; Eis V; Urban M; Mandys V Steroids; 2007 Apr; 72(4):375-80. PubMed ID: 17368496 [TBL] [Abstract][Full Text] [Related]
5. The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer. Nishiyama T; Hashimoto Y; Takahashi K Clin Cancer Res; 2004 Nov; 10(21):7121-6. PubMed ID: 15534082 [TBL] [Abstract][Full Text] [Related]
6. Influence of radical prostatectomy on serum hormone levels. Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896 [TBL] [Abstract][Full Text] [Related]
7. Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer. Titus MA; Schell MJ; Lih FB; Tomer KB; Mohler JL Clin Cancer Res; 2005 Jul; 11(13):4653-7. PubMed ID: 16000557 [TBL] [Abstract][Full Text] [Related]
8. Intraprostatic testosterone and dihydrotestosterone. Part II: concentrations after androgen hormonal manipulation in men with benign prostatic hyperplasia and prostate cancer. van der Sluis TM; Meuleman EJ; van Moorselaar RJ; Bui HN; Blankenstein MA; Heijboer AC; Vis AN BJU Int; 2012 Jan; 109(2):183-8. PubMed ID: 21992404 [TBL] [Abstract][Full Text] [Related]
9. Flutamide versus orchidectomy in the treatment of metastatic prostate carcinoma. Boccon-Gibod L; Fournier G; Bottet P; Marechal JM; Guiter J; Rischman P; Hubert J; Soret JY; Mangin P; Mallo C; Fraysse CE Eur Urol; 1997; 32(4):391-5; discussion 395-6. PubMed ID: 9412794 [TBL] [Abstract][Full Text] [Related]
10. Effect of orchidectomy on serum concentrations of testosterone and dihydrotestosterone in patients with prostatic cancer. Røhl HF; Beuke HP Scand J Urol Nephrol; 1992; 26(1):11-4. PubMed ID: 1631501 [TBL] [Abstract][Full Text] [Related]
11. [Bromocriptine and prostatic carcinoma: testosterone metabolism in relation to tumor grading (author's transl)]. Jacobi GH; Kurth KH; Altwein JE Urologe A; 1979 Mar; 18(2):91-8. PubMed ID: 433016 [TBL] [Abstract][Full Text] [Related]
12. Testosterone-mediated increase in 5 alpha-dihydrotestosterone content, nuclear androgen receptor levels, and cell division in an androgen-independent prostate carcinoma of Noble rats. Ho SM; Leav I; Damassa D; Kwan PW; Merk FB; Seto HS Cancer Res; 1988 Feb; 48(3):609-14. PubMed ID: 3257169 [TBL] [Abstract][Full Text] [Related]
13. [Testosterone in saliva: application to the follow-up of prostate cancer]. Navarro-Moreno MA; Rivera-Coll A Rev Esp Fisiol; 1990 Mar; 46(1):63-8. PubMed ID: 2204093 [TBL] [Abstract][Full Text] [Related]
14. The change in the dihydrotestosterone level in the prostate before and after androgen deprivation therapy in connection with prostate cancer aggressiveness using the Gleason score. Nishiyama T; Ikarashi T; Hashimoto Y; Wako K; Takahashi K J Urol; 2007 Oct; 178(4 Pt 1):1282-8; discussion 1288-9. PubMed ID: 17698092 [TBL] [Abstract][Full Text] [Related]
15. Adrenal steroid levels in castrated men with prostatic carcinoma treated with aminoglutethimide plus hydrocortisone. Ahmann FR; Crawford ED; Kreis W; Levasseur Y Cancer Res; 1987 Sep; 47(17):4736-9. PubMed ID: 3621171 [TBL] [Abstract][Full Text] [Related]
16. The baboon prostate as a model for steroid hormone receptors in the human gland. Karr JP; Kirdani RY; Murphy GP; Sandberg AA Prog Clin Biol Res; 1979; 33():165-79. PubMed ID: 119228 [No Abstract] [Full Text] [Related]
17. [Inhibition of the free, biologically active testosterone level by Turisteron in patients with prostate cancer]. Stahl F; Schnorr D; Rohde W; Dörner G Z Urol Nephrol; 1987 Mar; 80(3):135-8. PubMed ID: 3604472 [TBL] [Abstract][Full Text] [Related]
18. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial. Chen C; Weiss NS; Stanczyk FZ; Lewis SK; DiTommaso D; Etzioni R; Barnett MJ; Goodman GE Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1410-6. PubMed ID: 14693730 [TBL] [Abstract][Full Text] [Related]
19. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma. Nolten WE; Sholiton LJ; Srivastava LS; Knowles HC; Werk EE J Clin Endocrinol Metab; 1976 Dec; 43(6):1226-33. PubMed ID: 1002814 [TBL] [Abstract][Full Text] [Related]
20. Subcapsular orchidectomy in the management of prostatic carcinoma in Nigerians. Magoha GA East Afr Med J; 1989 Jun; 66(6):400-3. PubMed ID: 2791945 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]